Collective roles of molecular chaperones in protein degradation pathways associated with neurodegenerative diseases

Current Pharmaceutical Biotechnology

Volumn 11, Issue 2, 2010, Pages 180-187

  Luo, Guang Rui ^a   Le, Wei Dong ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Autophagy lysosome pathway; Chaperone mediated autophagy; Inclustion body; Molecular chaperones; Neurodegenerative disease; Proteasome ubiquitin system

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; CHAPERONE; COPPER ZINC SUPEROXIDE DISMUTASE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; POLYGLUTAMINE; PRESENILIN 1; PROTEASOME; SMALL HEAT SHOCK PROTEIN; TAU PROTEIN; UBIQUITIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; AUTOPHAGY; CELL INCLUSION; DEGENERATIVE DISEASE; FIBER; HUMAN; HUNTINGTON CHOREA; LYSOSOME; MOLECULAR INTERACTION; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW;

ANIMALS; AUTOPHAGY; BRAIN; HUMANS; INCLUSION BODIES; MOLECULAR CHAPERONES; NEURODEGENERATIVE DISEASES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN FOLDING; SIGNAL TRANSDUCTION; SOLUBILITY; UBIQUITIN;

EID: 77949902558     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920110790909740     Document Type: Review

References (79)

1. Thompson, S.J.; Loftus, L.T.; Ashley, M.D.; Meller, R. Ubiquitin-proteasome system as a modulator of cell fate. Curr. Opin. Pharmacol., 2008, 8 (1), 90-95.
2. Massey, A.C.; Zhang, C.; Cuervo, A.M. Chaperone-mediated autophagy in aging and disease. Curr. Top. Dev. Biol., 2006, 73, 205-235.
3. Nakamura, T.; Gu, Z.; Lipton, S.A. Contribution of glutamatergic signaling to nitrosative stress-induced protein misfolding in normal brain aging and neurodegenerative diseases. Aging Cell, 2007, 6(3), 351-359.
4. Oddo, S.; Caccamo, A.; Tseng, B.; Cheng, D.; Vasilevko, V.; Cribbs, D.H.; LaFerla, F.M. Blocking Abeta42 accumulation delays the onset and progression of tau pathology via the C terminus of heat shock protein70-interacting protein: a mechanistic link between Abeta and tau pathology. J. Neurosci., 2008, 28(47), 12163-12175.
5. Dickey, C.A.; Kamal, A.; Lundgren, K.; Klosak, N.; Bailey, R.M.; Dunmore, J.; Ash, P.; Shoraka, S.; Zlatkovic, J.; Eckman, C.B.; Patterson, C.; Dickson, D.W.; Ahman, N.S. Jr.; Hutton, M.; Burrows, F.; Petrucelli, L. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. J. Clin. Invest., 2007, 117 (3), 648-658.
6. Xilouri, M.; Vogiatzi, T.; Vekrellis, K.; Stefanis, L. alpha-synuclein degradation by autophagic pathways: a potential key to Parkinson's disease pathogenesis. Autophagy, 2008, 4 (7), 917-919.
7. Dedmon, M.M.; Christodoulou, J.; Wilson, M.R.; Dobson, C.M. Heat shock protein 70 inhibits alpha-synuclein fibril formation via preferential binding to prefibrillar species. J. Biol. Chem., 2005, 280(15), 14733-14740.
8. Wang, J.; Martin, E.; Gonzales, V.; Borchelt, D.R.; Lee, M.K. Differential regulation of small heat shock proteins in transgenic mouse models of neurodegenerative diseases. Neurobiol. Aging, 2008, 29(4), 586-597.
9. Gil, J.M.; Rego, A.C. Mechanisms of neurodegeneration in Huntington's disease. Eur. J Neurosci., 2008, 27 (11), 2803-2820.
10. Kalmar, B.; Kieran, D.; Greensmith, L. Molecular chaperones as therapeutic targets in amyotrophic lateral sclerosis. Biochem. Soc. Trans., 2005, 33 (Pt 4), 551-552.
11. Lian, H.Y.; Zhang, H.; Zhang, Z.R.; Loovers, H.M.; Jones, G.W.; Rowling, P.J.; Itzhaki, L.S.; Zhou, J.M.; Perrett, S. Hsp40 interacts directly with the native state of the yeast prion protein Ure2 and inhibits formation of amyloid-like fibrils. J. Biol. Chem., 2007, 282(16), 11931-11940.
12. Ciechanover, A.; Brundin, P. The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron, 2003, 40(2), 427-446.
13. Pan, T.; Kondo, S.; Le, W.; Jankovic, J. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. Brain, 2008, 131(Pt 8), 1969-1978.
14. Shen, S.; Zhang, P.; Lovchik, M.A.; Li, Y.; Tang, L.; Chen, Z.; Zeng, R.; Ma, D.; Yuan, J.; Yu, Q. Cyclodepsipeptide toxin promotes the degradation of Hsp90 client proteins through chaperone-mediated autophagy. J. Cell Biol., 2009, 185(4), 629-639.
15. Pandey, U.B.; Nie, Z.; Batlevi, Y.; McCray, B.A.; Ritson, G.P.; Nedelsky, N.B.; Schwartz, S.L.; DiProspero, N.A.; Knight, M.A.; Schuldiner, O.; Padmanabhan, R.; Hild, M.; Berry, D.L.; Garza, D.; Hubbert, C.C.; Yao, T.P.; Baehrecke, E.H.; Taylor, J.P. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature, 2007, 447 (7146), 859-863.
16. Cuervo, A.M. Autophagy: in sickness and in health. Trends Cell Biol., 2004, 14 (2), 70-77.
17. Hohfeld, J.; Cyr, D.M.; Patterson, C. From the cradle to the grave: molecular chaperones that may choose between folding and degradation. EMBO Rep., 2001, 2 (10), 885-890.
18. Goldbaum, O.; Oppermann, M.; Handschuh, M.; Dabir, D.; Zhang, B.; Forman, M.S.; Trojanowski, J.Q.; Lee, V.M.; Richter-Landsberg, C. Proteasome inhibition stabilizes tau inclusions in oligodendroglial cells that occur after treatment with okadaic acid. J. Neurosci., 2003, 23(26), 8872-8880.
19. Yamano, T.; Mizukami, S.; Murata, S.; Chiba, T.; Tanaka, K.; Udono, H. Hsp90-mediated assembly of the 26 S proteasome is involved in major histocompatibility complex class I antigen processing. J. Biol. Chem., 2008, 283(42), 28060-28065.
20. Williams, A.J.; Knutson, T.M.; Colomer, G.V.F.; Paulson, H.L. In vivo suppression of polyglutamine neurotoxicity by C-terminus of Hsp70-interacting protein (CHIP) supports an aggregation model of pathogenesis. Neurobiol. Dis., 2009, 33 (3), 342-353.
21. Cuervo, A.M.; Stefanis, L.; Fredenburg, R.; Lansbury, P.T.; Sulzer, D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science, 2004, 305(5688), 1292-1295.
22. Yang, Q.; She, H.; Gearing, M.; Colla, E.; Lee, M.; Shacka, J.J.; Mao, Z. Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy. Science, 2009, 323(5910), 124-127.
23. Ryhanen, T.; Hyttinen, J.M.; Kopitz, J.; Rilla, K.; Kuusisto, E.; Mannermaa, E.; Viiri, J.; Holmberg, C.I.; Immonen, I.; Meri, S.; Parkkinen, J.; Eskelinen, E.L.; Uusitalo, H.; Salminen, A.; Kaarniranta, K. Crosstalk between Hsp70 molecular chaperone, lysosomes and proteasomes in autophagy-mediated proteolysis in human retinal pigment epithelial cells. J. Cell Mol. Med., 2008, [Epub ahead of Print].
24. Kiffin, R.; Kaushik, S.; Zeng, M.; Bandyopadhyay, U.; Zhang, C.; Massey, A.C.; Martinez-Vicente, M.; Cuervo, A.M. Altered dynamics of the lysosomal receptor for chaperone-mediated autophagy with age. J. Cell Sci., 2007, 120(Pt 5), 782-791.
25. Massey, A.C.; Kaushik, S.; Sovak, G.; Kiffin, R.; Cuervo, A.M. Consequences of the selective blockage of chaperone-mediated autophagy. Proc. Natl. Acad. Sci. USA, 2006, 103(15), 5805-5810.
26. Paz Gavilan, M.; Vela, J.; Castano, A.; Ramos, B.; del Rio, J.C.; Vitorica, J.; Ruano, D. Cellular environment facilitates protein accumulation in aged rat hippocampus. Neurobiol. Aging, 2006, 27(7), 973-982.
27. Min, J.N.; Whaley, R.A.; Sharpless, N.E.; Lockyer, P.; Portbury, A.L.; Patterson, C. CHIP deficiency decreases longevity, with accelerated aging phenotypes accompanied by altered protein quality control. Mol. Cell Biol., 2008, 28 (12), 4018-4025.
28. Massey, A.C.; Kiffin, R.; Cuervo, A.M. Autophagic defects in aging: looking for an "emergency exit"? Cell Cycle, 2006, 5(12), 1292-1296.
29. Wang, L.; Xie, C.; Greggio, E.; Parisiadou, L.; Shim, H.; Sun, L.; Chandran, J.; Lin, X.; Lai, C.; Yang, W.J.; Moore, D.J.; Dawson, T.M.; Dawson, V.L.; Chiosis, G.; Cookson, M.R.; Cai, H. The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2. J. Neurosci., 2008, 28 (13), 3384-3391.
30. Luo, W.; Dou, F.; Rodina, A.; Chip, S.; Kim, J.; Zhao, Q.; Moulick, K.; Aguirre, J.; Wu, N.; Greengard, P.; Chiosis, G. Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies. Proc. Natl. Acad. Sci. USA, 2007, 104(22), 9511-9516.
31. Kopito, R.R. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol., 2000, 10 (12), 524-530.
32. Liu, J.; Zhang, J.P.; Shi, M.; Quinn, T.; Bradner, J.; Beyer, R.; Chen, S.; Zhang, J. Rab11a and HSP90 regulate recycling of extracellular alpha-synuclein. J. Neurosci., 2009, 29 (5), 1480-1485.
33. Outeiro, T.F.; Putcha, P.; Tetzlaff, J.E.; Spoelgen, R.; Koker, M.; Carvalho, F.; Hyman, B.T.; McLean, P.J. Formation of toxic oligomeric alpha-synuclein species in living cells. PLoS ONE, 2008, 3 (4), e1867.
34. Moore, D.J.; West, A.B.; Dawson, V.L.; Dawson, T.M. Molecular pathophysiology of Parkinson's disease. Annu. Rev. Neurosci., 2005, 28, 57-87.
35. Uryu, K.; Richter-Landsberg, C.; Welch, W.; Sun, E.; Goldbaum, O.; Norris, E.H.; Pham, C.T.; Yazawa, I.; Hilburger, K.; Micsenyi, M.; Giasson, B.I.; Bonini, N.M.; Lee, V.M.; Trojanowski, J.Q. Convergence of heat shock protein 90 with ubiquitin in filamentous alpha-synuclein inclusions of alpha-synucleinopathies. Am. J. Pathol., 2006, 168(3), 947-961.
36. Zhang, W.; Wang, T.; Pei, Z.; Miller, D.S.; Wu, X.; Block, M.L.; Wilson, B.; Zhang, W.; Zhou, Y.; Hong, J.S.; Zhang, J. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J., 2005, 19(6), 533-542.
37. Cooper, A.A.; Gitler, A.D.; Cashikar, A.; Haynes, C.M.; Hill, K.J.; Bhullar, B.; Liu, K.; Xu, K.; Strathearn, K.E.; Liu, F.; Cao, S.; Caldwell, K.A.; Caldwell, G.A.; Marsischky, G.; Kolodner, R.D.; Labaer, J.; Rochet, J.C.; Bonini, N.M.; Lindquist, S. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science, 2006, 313(5785), 324-328.
38. Gitler, A.D.; Bevis, B.J.; Shorter, J.; Strathearn, K.E.; Hamamichi, S.; Su, L.J.; Caldwell, K.A.; Caldwell, G.A.; Rochet, J.C.; McCaffery, J.M.; Barlowe, C.; Lindquist, S. The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc. Natl. Acad. Sci. USA, 2008, 105(1), 145-150.
39. Klucken, J.; Shin, Y.; Masliah, E.; Hyman, B.T.; McLean, P.J. Hsp70 Reduces alpha-synuclein aggregation and toxicity. J. Biol. Chem., 2004, 279 (24), 25497-25502.
40. Auluck, P.K.; Meulener, M.C.; Bonini, N.M. Mechanisms of Suppression of {alpha}-Synuclein neurotoxicity by geldanamycin in drosophila. J. Biol. Chem., 2005, 280(4), 2873-2878.
41. Huang, C.; Cheng, H.; Hao, S.; Zhou, H.; Zhang, X.; Gao, J.; Sun, Q.H.; Hu, H.; Wang, C.C. Heat shock protein 70 inhibits alpha-synuclein fibril formation via interactions with diverse intermediates. J. Mol. Biol., 2006, 364 (3), 323-336.
42. Rideout, H.J.; Lang-Rollin, I.C.; Savalle, M.; Stefanis, L. Dopaminergic neurons in rat ventral midbrain cultures undergo selective apoptosis and form inclusions, but do not up-regulate iHSP70, following proteasomal inhibition. J. Neurochem., 2005, 93 (5), 1304-1313.
43. Outeiro, T.F.; Klucken, J.; Strathearn, K.E.; Liu, F.; Nguyen, P.; Rochet, J.C.; Hyman, B.T.; McLean, P.J. Small heat shock proteins protect against alpha-synuclein-induced toxicity and aggregation. Biochem. Biophys. Res. Commun., 2006, 351(3), 631-638.
44. Liao, P.C.; Lin, H.Y.; Yuh, C.H.; Yu, L.K.; Wang, H.D. The effect of neuronal expression of heat shock proteins 26 and 27 on lifespan, neurodegeneration, and apoptosis in Drosophila. Biochem. Biophys. Res. Commun., 2008, 376 (4), 637-641.
45. Goldbaum, O.; Riedel, M.; Stahnke, T.; Richter-Landsberg, C. The small heat shock protein HSP25 protects astrocytes against stress induced by proteasomal inhibition. Glia, 2009, 57(14),1566-1577.
46. Xilouri, M.; Vogiatzi, T.; Vekrellis, K.; Park, D.; Stefanis, L. Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. PLoS ONE, 2009, 4(5), e5515.
47. Emmanouilidou, E.; Stefanis, L.; Vekrellis, K. Cell-produced alpha-synuclein oligomers are targeted to, and impair, the 26S proteasome. Neurobiol. Aging, 2008, [Epub ahead of Print].
48. Lindersson, E.; Beedholm, R.; Hojrup, P.; Moos, T.; Gai, W.; Hendil, K.B.; Jensen, P.H. Proteasomal inhibition by alpha-synuclein filaments and oligomers. J. Biol. Chem., 2004, 279 (13), 12924-12934.
49. Martinez-Vicente, M.; Talloczy, Z.; Kaushik, S.; Massey, A.C.; Mazzulli, J.; Mosharov, E.V.; Hodara, R.; Fredenburg, R.; Wu, D.C.; Follenzi, A.; Dauer, W.; Przedborski, S.; Ischiropoulos, H.; Lansbury, P.T.; Sulzer, D.; Cuervo, A.M. Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J. Clin. Invest., 2008, 118 (2), 777-788.
50. Vogiatzi, T.; Xilouri, M.; Vekrellis, K.; Stefanis, L. Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J. Biol. Chem., 2008, 283 (35), 23542-23556.
51. Tsai, Y.C.; Fishman, P.S.; Thakor, N.V.; Oyler, G.A. Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function. J. Biol. Chem., 2003, 278(24), 22044-22055.
52. Kabuta, T.; Furuta, A.; Aoki, S.; Furuta, K.; Wada, K. Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy. J. Biol. Chem., 2008, 283 (35), 23731-23738.
53. Lesage, S.; Leutenegger, A.L.; Ibanez, P.; Janin, S.; Lohmann, E.; Durr, A.; Brice, A. LRRK2 haplotype analyses in European and North African families with Parkinson disease: a common founder for the G2019S mutation dating from the 13th century. Am. J. Hum. Genet., 2005, 77 (2), 330-332.
54. Batelli, S.; Albani, D.; Rametta, R.; Polito, L.; Prato, F.; Pesaresi, M.; Negro, A.; Forloni, G. DJ-1 modulates alpha-synuclein aggregation state in a cellular model of oxidative stress: relevance for Parkinson's disease and involvement of HSP70. PLoS ONE, 2008, 3 (4), e1884.
55. Goldbaum, O.; Richter-Landsberg, C. Proteolytic stress causes heat shock protein induction, tau ubiquitination, and the recruitment of ubiquitin to tau-positive aggregates in oligodendrocytes in culture. J. Neurosci., 2004, 24 (25), 5748-5757.
56. Petrucelli, L.; Dickson, D.; Kehoe, K.; Taylor, J.; Snyder, H.; Grover, A.; De Lucia, M.; McGowan, E.; Lewis, J.; Prihar, G.; Kim, J.; Dillmann, W.H.; Browne, S.E.; Hall, A.; Voellmy, R.; Tsuboi, Y.; Dawson, T.M.; Wolozin, B.; Hardy, J.; Hutton, M. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum. Mol. Genet., 2004, 13 (7), 703-714.
57. Shimura, H.; Schwartz, D.; Gygi, S.P.; Kosik, K.S. CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J. Biol. Chem., 2004, 279 (6), 4869-4876.
58. Hatakeyama, S.; Matsumoto, M.; Kamura, T.; Murayama, M.; Chui, D.H.; Planel, E.; Takahashi, R.; Nakayama, K.I.; Takashima, A. U-box protein carboxyl terminus of Hsc70-interacting protein (CHIP) mediates poly-ubiquitylation preferentially on four-repeat Tau and is involved in neurodegeneration of tauopathy. J. Neurochem., 2004, 91(2), 299-307.
59. Nemes, Z.; Devreese, B.; Steinert, P.M.; Van Beeumen, J.; Fesus, L. Cross-linking of ubiquitin, HSP27, parkin, and alpha-synuclein by gamma-glutamyl-epsilon-lysine bonds in Alzheimer's neurofibrillary tangles. FASEB J., 2004, 18(10), 1135-1137.
60. Dickey, C.A.; Dunmore, J.; Lu, B.; Wang, J.W.; Lee, W.C.; Kamal, A.; Burrows, F.; Eckman, C.; Hutton, M.; Petrucelli, L. HSP induction mediates selective clearance of tau phosphorylated at proline-directed Ser/Thr sites but not KXGS (MARK) sites. FASEB J., 2006, 20(6), 753-755.
61. Evans, C.G.; Wisen, S.; Gestwicki, J.E. Heat shock proteins 70 and 90 inhibit early stages of amyloid beta-(1-42) aggregation in vitro. J. Biol. Chem., 2006, 281(44), 33182-33191.
62. Matsumoto, G.; Stojanovic, A.; Holmberg, C.I.; Kim, S.; Morimoto, R.I. Structural properties and neuronal toxicity of amyotrophic lateral sclerosis-associated Cu/Zn superoxide dismutase 1 aggregates. J. Cell Biol., 2005, 171(1), 75-85.
63. Liu, J.; Shinobu, L.A.; Ward, C.M.; Young, D.; Cleveland, D.W. Elevation of the Hsp70 chaperone does not effect toxicity in mouse models of familial amyotrophic lateral sclerosis. J. Neurochem., 2005, 93(4), 875-882.
64. Gifondorwa, D.J.; Robinson, M.B.; Hayes, C.D.; Taylor, A.R.; Prevette, D.M.; Oppenheim, R.W.; Caress, J.; Milligan, C.E. Exogenous delivery of heat shock protein 70 increases lifespan in a mouse model of amyotrophic lateral sclerosis. J. Neurosci., 2007, 27(48), 13173-13180.
65. Kalmar, B.; Novoselov, S.; Gray, A.; Cheetham, M.E.; Margulis, B.; Greensmith, L. Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1 mouse model of ALS. J. Neurochem., 2008, 107 (2), 339-350.
66. Krishnan, J.;Vannuvel, K.; Andries, M.; Waelkens, E.; Robberecht, W.; Van Den Bosch, L. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis. J. Neurochem., 2008, 106(5), 2170-2183.
67. Fayazi, Z.; Ghosh, S.; Marion, S.; Bao, X.; Shero, M.; Kazemi-Esfarjani, P. A Drosophila ortholog of the human MRJ modulates polyglutamine toxicity and aggregation. Neurobiol. Dis., 2006, 24 (2), 226-244.
68. Krobitsch, S.; Lindquist, S. Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc. Natl. Acad. Sci. USA, 2000, 97(4), 1589-1594.
69. Novoselova, T.V.; Margulis, B.A.; Novoselov, S.S.; Sapozhnikov, A.M.; van der Spuy, J.; Cheetham, M.E.; Guzhova, I.V. Treatment with extracellular HSP70/HSC70 protein can reduce polyglutamine toxicity and aggregation. J. Neurochem., 2005, 94(3), 597-606.
70. Wacker, J.L.; Huang, S.Y.; Steele, A.D.; Aron, R.; Lotz, G.P.; Nguyen, Q.; Giorgini, F.; Roberson, E.D.; Lindquist, S.; Masliah, E.; Muchowski, P.J. Loss of Hsp70 exacerbates pathogenesis but not levels of fibrillar aggregates in a mouse model of Huntington's disease. J. Neurosci., 2009, 29(28), 9104-9114.
71. Miller, V.M.; Nelson, R.F.; Gouvion, C.M.; Williams, A.; Rodriguez-Lebron, E.; Harper, S.Q.; Davidson, B.L.; Rebagliati, M.R.; Paulson, H.L. CHIP suppresses polyglutamine aggregation and toxicity in vitro and in vivo. J. Neurosci., 2005, 25(40), 9152-9161.
72. Fujimoto, M.; Takaki, E.; Hayashi, T.; Kitaura, Y.; Tanaka, Y.; Inouye, S.; Nakai, A. Active HSF1 significantly suppresses polyglutamine aggregate formation in cellular and mouse models. J. Biol. Chem., 2005, 280(41), 34908-34916.
73. Perrin, V.; Regulier, E.; Abbas-Terki, T.; Hassig, R.; Brouillet, E.; Aebischer, P.; Luthi-Carter, R.; Deglon, N. Neuroprotection by Hsp104 and Hsp27 in lentiviral-based rat models of Huntington's disease. Mol. Ther., 2007, 15(5), 903-911.
74. Schiffer, N.W.; Broadley, S.A.; Hirschberger, T.; Tavan, P.; Kretzschmar, H.A.; Giese, A.; Haass, C.; Hartl, F.U.; Schmid, B. Identification of anti-prion compounds as efficient inhibitors of polyglutamine protein aggregation in a zebrafish model. J. Biol. Chem., 2007, 282 (12), 9195-9203.
75. McLear, J.A.; Lebrecht, D.; Messer, A.; Wolfgang, W.J. Combinational approach of intrabody with enhanced Hsp70 expression addresses multiple pathologies in a fly model of Huntington's disease. FASEB J., 2008, 22(6), 2003-2011.
76. Kristiansen, M.; Deriziotis, P.; Dimcheff, D.E.; Jackson, G.S.; Ovaa, H.; Naumann, H.; Clarke, A.R.; van Leeuwen, F.W.; Menendez-Benito, V.; Dantuma, N.P.; Portis, J.L.; Collinge, J.; Tabrizi, S.J. Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol. Cell, 2007, 26(2), 175-188.
77. Shorter, J.; Lindquist, S. Hsp104, Hsp70 and Hsp40 interplay regulates formation, growth and elimination of Sup35 prions. EMBO J., 2008, 27(20), 2712-2724.
78. Summers, D.W.; Douglas, P.M.; Ren, H.Y.; Cyr, D.M. The type I Hsp40 Ydj1 utilizes a farnesyl moiety and zinc finger-like region to suppress prion toxicity. J. Biol. Chem., 2009, 284(6), 3628-3639.
79. Hinault, M.P.; Ben-Zvi, A.; Goloubinoff, P. Chaperones and proteases: cellular fold-controlling factors of proteins in neurodegenerative diseases and aging. J. Mol. Neurosci., 2006, 30 (3), 249-265.